1. Home
  2. CAE vs RGEN Comparison

CAE vs RGEN Comparison

Compare CAE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

HOLD

Current Price

$27.74

Market Cap

8.5B

Sector

N/A

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$161.47

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAE
RGEN
Founded
1947
1981
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CAE
RGEN
Price
$27.74
$161.47
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
$33.75
$170.90
AVG Volume (30 Days)
607.6K
797.9K
Earning Date
11-11-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.97
0.03
Revenue
$3,470,482,234.00
$707,890,000.00
Revenue This Year
$6.40
$17.84
Revenue Next Year
$5.69
$12.57
P/E Ratio
$28.58
$6,320.44
Revenue Growth
9.12
11.74
52 Week Low
$20.36
$102.97
52 Week High
$30.13
$182.52

Technical Indicators

Market Signals
Indicator
CAE
RGEN
Relative Strength Index (RSI) 62.92 55.02
Support Level $27.07 $160.11
Resistance Level $28.58 $170.40
Average True Range (ATR) 0.60 5.38
MACD 0.24 -0.84
Stochastic Oscillator 78.57 45.31

Price Performance

Historical Comparison
CAE
RGEN

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: